Table 1 Patient characteristics (n = 587).
Characteristics | VTE (+) n (%) | VTE (−) n (%) | Total n (%) | P-value |
|---|---|---|---|---|
Gender | 0.277 | |||
Male | 77 (53.8) | 262 (59.0) | 339 (57.8) | |
Female | 66 (46.2) | 182 (41.0) | 248 (42.2) | |
Age (years) | 0.945 | |||
Mean (min–max) | 4.7 (0.1–16) | 4.7 (0.3–13) | 4.7 | |
Median | 4.0 | 4.0 | 4.0 | |
BMI | 0.426 | |||
Mean (min–max) | 15.6 (10.2–25.6) | 15.6 (10.1–27.6) | 15.6 | |
Median | 15.3 | 15.3 | 15.3 | |
Stage | 0.969 | |||
Early | 39 (27.3) | 117 (26.4) | 156 (26.6) | |
Advanced | 98 (68.5) | 307 (69.1) | 405 (69.0) | |
Recurrence | 6 (4.2) | 20 (4.5) | 26 (4.4) | |
WBC (× 109/L) | 0.617 | |||
Mean (min–max) | 8.6 (1.28–23.01) | 8.4 (0.79–63.09) | 8.4 | |
Median | 8.14 | 7.4 | 7.6 | |
Hemoglobin (g/L) | 0.073 | |||
Mean (min–max) | 114.3 (55–155) | 110.7 (28–158) | 111.6 | |
Median | 118.0 | 115.0 | 115.0 | |
Platelet count (× 109/L) | 0.001 | |||
Mean (min–max) | 381.3 (37–1156) | 336.9 (9–1020) | 347.7 | |
Median | 377.0 | 322.0 | 332.5 | |
Albumin (g/L) | 0.745 | |||
Mean (min–max) | 43.5 (30.2–114.8) | 43.7 (23.2–197.1) | 43.6 | |
Median | 43.5 | 43.3 | 43.3 | |
d-Dimer (mg/L) | 0.411 | |||
Mean (min–max) | 8.5 (0.09–121.19) | 10.1 (0.05–129.09) | 9.7 | |
Median | 0.9 | 1.2 | 1.1 | |
APTT (s) | 0.469 | |||
Mean(min–max) | 24.4 (0.1–42.2) | 25.4 (0.12–121) | 25.1 | |
Median | 27.3 | 27.8 | 27.6 | |
INR | 0.239 | |||
Mean (min–max) | 1.01 (0.79–1.31) | 1.06 (0.82–1.77) | 1.06 | |
Median | 1.02 | 1.04 | 1.03 | |
CRP (mg/L) | 0.002 | |||
Mean (min–max) | 8.2 (0.03–88.12) | 14.9 (0.02–300.9) | 13.3 | |
Median | 1.2 | 1.6 | 1.5 | |
Distancea (mm) | 0.05 | |||
Mean (min–max) | 17.1 (7–41) | 15.8 (5–58) | 16.1 | |
Median | 15.5 | 15.0 | 15.0 | |
Drugb | 0.273 | |||
a | 106 (74.1) | 353 (79.5) | 459 (78.2) | |
b | 18 (12.6) | 37 (8.3) | 55 (9.4) | |
c | 19 (13.3) | 54 (12.2) | 73 (12.4) |
